PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
23.54
-0.26 (-1.09%)
At close: Nov 16, 2026, 4:00 PM EST
23.53
-0.01 (-0.04%)
Pre-market: Nov 17, 2026, 7:00 AM EST

PROCEPT BioRobotics Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, PROCEPT BioRobotics stock has a consensus rating of "Hold" and an average price target of $22.75. The average 1-year stock price forecast is 3.36% lower than the current stock price, while the lowest is $16 (-32.03%) and the highest is $30 (+27.44%).

Price Target: $22.75 (-3.36%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$16$22.75$23$30
Change-32.03%-3.36%-2.29%+27.44%

Analyst Ratings

The average analyst rating for PROCEPT BioRobotics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy653333
Buy111122
Hold579999
Sell111111
Strong Sell000000
Total131414141515

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Truist Financial
Truist Financial
Hold
Reiterates
$21 → $24
HoldReiterates$21 → $24+1.95%Nov 6, 2026
Unknown Analyst
Oppenheimer
No rating
Oppenheimer
Hold
Maintains
n/a
HoldMaintainsn/an/aNov 6, 2026
Bank of America Securities
Bank of America Securities
Sell
Maintains
n/a
SellMaintainsn/an/aNov 5, 2026
Leerink Partners
Leerink Partners
Hold
Reiterates
$20 → $22
HoldReiterates$20 → $22-6.54%Nov 5, 2026
TD Cowen
TD Cowen
Buy
Reiterates
$28
BuyReiterates$28+18.95%Nov 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
395.65M
from 308.05M
Increased by 28.44%
Revenue Next Year
474.85M
from 395.65M
Increased by 20.02%
EPS This Year
-1.72
from -1.72
EPS Next Year
-1.23
from -1.72
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
34.47M75.01M136.19M224.50M308.05M395.65M
Revenue Growth
346.72%117.60%81.55%64.84%37.22%28.44%
Gross Profit
15.87M37.09M71.05M137.10M196.23M258.88M
Gross Margin
46.02%49.44%52.17%61.07%63.70%65.43%
Operating Income
-54.16M-80.72M-109.17M-96.61M-103.86M-101.01M
Net Income
-59.85M-87.15M-105.90M-91.41M-95.57M-97.76M
EPS
-----1.72-1.72
Free Cash Flow
-----58.34M-47.95M
No. Analysts
-----13
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High401.5M
Avg395.6M
Low389.0M

Revenue Growth

Revenue Growth202620272028
High
30.3%
Avg
28.4%
Low
26.3%

EPS Forecast

EPS202620272028
High-1.63
Avg-1.72
Low-1.80

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-